Global Infectious Diseases In Vitro Diagnostics Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Page: 106

Published Date: 02 Jan 2024

Category: Medical Care

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

According to our (Global Info Research) latest study, the global Infectious Diseases In Vitro Diagnostics market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

The Global Info Research report includes an overview of the development of the Infectious Diseases In Vitro Diagnostics industry chain, the market status of Immunochemistry (MRSA, Streptococcus), Molecular Diagnostics (MRSA, Streptococcus), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Infectious Diseases In Vitro Diagnostics.

Regionally, the report analyzes the Infectious Diseases In Vitro Diagnostics markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Infectious Diseases In Vitro Diagnostics market, with robust domestic demand, supportive policies, and a strong manufacturing base.

Key Features:
The report presents comprehensive understanding of the Infectious Diseases In Vitro Diagnostics market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Infectious Diseases In Vitro Diagnostics industry.

The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., MRSA, Streptococcus).

Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Infectious Diseases In Vitro Diagnostics market.

Regional Analysis: The report involves examining the Infectious Diseases In Vitro Diagnostics market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.

Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Infectious Diseases In Vitro Diagnostics market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.

The report also involves a more granular approach to Infectious Diseases In Vitro Diagnostics:
Company Analysis: Report covers individual Infectious Diseases In Vitro Diagnostics players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.

Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Infectious Diseases In Vitro Diagnostics This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Immunochemistry, Molecular Diagnostics).

Technology Analysis: Report covers specific technologies relevant to Infectious Diseases In Vitro Diagnostics. It assesses the current state, advancements, and potential future developments in Infectious Diseases In Vitro Diagnostics areas.

Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Infectious Diseases In Vitro Diagnostics market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.

Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.

Market Segmentation
Infectious Diseases In Vitro Diagnostics market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.

Market segment by Type
MRSA
Streptococcus
TB and Drug-resistant TB
Gastro-intestinal Panel Testing
HIV
Hepatitis C
Others

Market segment by Application
Immunochemistry
Molecular Diagnostics
Microbiology
Others

Market segment by players, this report covers
BD
Abbott
Alere
Quidel
F. Hoffmann-La Roche
Orasure Technologies
Cepheid
Hologic
Qiagen
Bio-Rad Laboratories
Siemens Healthcare

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Infectious Diseases In Vitro Diagnostics product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Infectious Diseases In Vitro Diagnostics, with revenue, gross margin and global market share of Infectious Diseases In Vitro Diagnostics from 2019 to 2024.
Chapter 3, the Infectious Diseases In Vitro Diagnostics competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Infectious Diseases In Vitro Diagnostics market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Infectious Diseases In Vitro Diagnostics.
Chapter 13, to describe Infectious Diseases In Vitro Diagnostics research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Infectious Diseases In Vitro Diagnostics
    1.2 Market Estimation Caveats and Base Year
    1.3 Classification of Infectious Diseases In Vitro Diagnostics by Type
        1.3.1 Overview: Global Infectious Diseases In Vitro Diagnostics Market Size by Type: 2019 Versus 2023 Versus 2030
        1.3.2 Global Infectious Diseases In Vitro Diagnostics Consumption Value Market Share by Type in 2023
        1.3.3 MRSA
        1.3.4 Streptococcus
        1.3.5 TB and Drug-resistant TB
        1.3.6 Gastro-intestinal Panel Testing
        1.3.7 HIV
        1.3.8 Hepatitis C
        1.3.9 Others
    1.4 Global Infectious Diseases In Vitro Diagnostics Market by Application
        1.4.1 Overview: Global Infectious Diseases In Vitro Diagnostics Market Size by Application: 2019 Versus 2023 Versus 2030
        1.4.2 Immunochemistry
        1.4.3 Molecular Diagnostics
        1.4.4 Microbiology
        1.4.5 Others
    1.5 Global Infectious Diseases In Vitro Diagnostics Market Size & Forecast
    1.6 Global Infectious Diseases In Vitro Diagnostics Market Size and Forecast by Region
        1.6.1 Global Infectious Diseases In Vitro Diagnostics Market Size by Region: 2019 VS 2023 VS 2030
        1.6.2 Global Infectious Diseases In Vitro Diagnostics Market Size by Region, (2019-2030)
        1.6.3 North America Infectious Diseases In Vitro Diagnostics Market Size and Prospect (2019-2030)
        1.6.4 Europe Infectious Diseases In Vitro Diagnostics Market Size and Prospect (2019-2030)
        1.6.5 Asia-Pacific Infectious Diseases In Vitro Diagnostics Market Size and Prospect (2019-2030)
        1.6.6 South America Infectious Diseases In Vitro Diagnostics Market Size and Prospect (2019-2030)
        1.6.7 Middle East and Africa Infectious Diseases In Vitro Diagnostics Market Size and Prospect (2019-2030)

2 Company Profiles
    2.1 BD
        2.1.1 BD Details
        2.1.2 BD Major Business
        2.1.3 BD Infectious Diseases In Vitro Diagnostics Product and Solutions
        2.1.4 BD Infectious Diseases In Vitro Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
        2.1.5 BD Recent Developments and Future Plans
    2.2 Abbott
        2.2.1 Abbott Details
        2.2.2 Abbott Major Business
        2.2.3 Abbott Infectious Diseases In Vitro Diagnostics Product and Solutions
        2.2.4 Abbott Infectious Diseases In Vitro Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
        2.2.5 Abbott Recent Developments and Future Plans
    2.3 Alere
        2.3.1 Alere Details
        2.3.2 Alere Major Business
        2.3.3 Alere Infectious Diseases In Vitro Diagnostics Product and Solutions
        2.3.4 Alere Infectious Diseases In Vitro Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
        2.3.5 Alere Recent Developments and Future Plans
    2.4 Quidel
        2.4.1 Quidel Details
        2.4.2 Quidel Major Business
        2.4.3 Quidel Infectious Diseases In Vitro Diagnostics Product and Solutions
        2.4.4 Quidel Infectious Diseases In Vitro Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
        2.4.5 Quidel Recent Developments and Future Plans
    2.5 F. Hoffmann-La Roche
        2.5.1 F. Hoffmann-La Roche Details
        2.5.2 F. Hoffmann-La Roche Major Business
        2.5.3 F. Hoffmann-La Roche Infectious Diseases In Vitro Diagnostics Product and Solutions
        2.5.4 F. Hoffmann-La Roche Infectious Diseases In Vitro Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
        2.5.5 F. Hoffmann-La Roche Recent Developments and Future Plans
    2.6 Orasure Technologies
        2.6.1 Orasure Technologies Details
        2.6.2 Orasure Technologies Major Business
        2.6.3 Orasure Technologies Infectious Diseases In Vitro Diagnostics Product and Solutions
        2.6.4 Orasure Technologies Infectious Diseases In Vitro Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
        2.6.5 Orasure Technologies Recent Developments and Future Plans
    2.7 Cepheid
        2.7.1 Cepheid Details
        2.7.2 Cepheid Major Business
        2.7.3 Cepheid Infectious Diseases In Vitro Diagnostics Product and Solutions
        2.7.4 Cepheid Infectious Diseases In Vitro Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
        2.7.5 Cepheid Recent Developments and Future Plans
    2.8 Hologic
        2.8.1 Hologic Details
        2.8.2 Hologic Major Business
        2.8.3 Hologic Infectious Diseases In Vitro Diagnostics Product and Solutions
        2.8.4 Hologic Infectious Diseases In Vitro Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
        2.8.5 Hologic Recent Developments and Future Plans
    2.9 Qiagen
        2.9.1 Qiagen Details
        2.9.2 Qiagen Major Business
        2.9.3 Qiagen Infectious Diseases In Vitro Diagnostics Product and Solutions
        2.9.4 Qiagen Infectious Diseases In Vitro Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
        2.9.5 Qiagen Recent Developments and Future Plans
    2.10 Bio-Rad Laboratories
        2.10.1 Bio-Rad Laboratories Details
        2.10.2 Bio-Rad Laboratories Major Business
        2.10.3 Bio-Rad Laboratories Infectious Diseases In Vitro Diagnostics Product and Solutions
        2.10.4 Bio-Rad Laboratories Infectious Diseases In Vitro Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
        2.10.5 Bio-Rad Laboratories Recent Developments and Future Plans
    2.11 Siemens Healthcare
        2.11.1 Siemens Healthcare Details
        2.11.2 Siemens Healthcare Major Business
        2.11.3 Siemens Healthcare Infectious Diseases In Vitro Diagnostics Product and Solutions
        2.11.4 Siemens Healthcare Infectious Diseases In Vitro Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
        2.11.5 Siemens Healthcare Recent Developments and Future Plans

3 Market Competition, by Players
    3.1 Global Infectious Diseases In Vitro Diagnostics Revenue and Share by Players (2019-2024)
    3.2 Market Share Analysis (2023)
        3.2.1 Market Share of Infectious Diseases In Vitro Diagnostics by Company Revenue
        3.2.2 Top 3 Infectious Diseases In Vitro Diagnostics Players Market Share in 2023
        3.2.3 Top 6 Infectious Diseases In Vitro Diagnostics Players Market Share in 2023
    3.3 Infectious Diseases In Vitro Diagnostics Market: Overall Company Footprint Analysis
        3.3.1 Infectious Diseases In Vitro Diagnostics Market: Region Footprint
        3.3.2 Infectious Diseases In Vitro Diagnostics Market: Company Product Type Footprint
        3.3.3 Infectious Diseases In Vitro Diagnostics Market: Company Product Application Footprint
    3.4 New Market Entrants and Barriers to Market Entry
    3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type
    4.1 Global Infectious Diseases In Vitro Diagnostics Consumption Value and Market Share by Type (2019-2024)
    4.2 Global Infectious Diseases In Vitro Diagnostics Market Forecast by Type (2025-2030)

5 Market Size Segment by Application
    5.1 Global Infectious Diseases In Vitro Diagnostics Consumption Value Market Share by Application (2019-2024)
    5.2 Global Infectious Diseases In Vitro Diagnostics Market Forecast by Application (2025-2030)

6 North America
    6.1 North America Infectious Diseases In Vitro Diagnostics Consumption Value by Type (2019-2030)
    6.2 North America Infectious Diseases In Vitro Diagnostics Consumption Value by Application (2019-2030)
    6.3 North America Infectious Diseases In Vitro Diagnostics Market Size by Country
        6.3.1 North America Infectious Diseases In Vitro Diagnostics Consumption Value by Country (2019-2030)
        6.3.2 United States Infectious Diseases In Vitro Diagnostics Market Size and Forecast (2019-2030)
        6.3.3 Canada Infectious Diseases In Vitro Diagnostics Market Size and Forecast (2019-2030)
        6.3.4 Mexico Infectious Diseases In Vitro Diagnostics Market Size and Forecast (2019-2030)

7 Europe
    7.1 Europe Infectious Diseases In Vitro Diagnostics Consumption Value by Type (2019-2030)
    7.2 Europe Infectious Diseases In Vitro Diagnostics Consumption Value by Application (2019-2030)
    7.3 Europe Infectious Diseases In Vitro Diagnostics Market Size by Country
        7.3.1 Europe Infectious Diseases In Vitro Diagnostics Consumption Value by Country (2019-2030)
        7.3.2 Germany Infectious Diseases In Vitro Diagnostics Market Size and Forecast (2019-2030)
        7.3.3 France Infectious Diseases In Vitro Diagnostics Market Size and Forecast (2019-2030)
        7.3.4 United Kingdom Infectious Diseases In Vitro Diagnostics Market Size and Forecast (2019-2030)
        7.3.5 Russia Infectious Diseases In Vitro Diagnostics Market Size and Forecast (2019-2030)
        7.3.6 Italy Infectious Diseases In Vitro Diagnostics Market Size and Forecast (2019-2030)

8 Asia-Pacific
    8.1 Asia-Pacific Infectious Diseases In Vitro Diagnostics Consumption Value by Type (2019-2030)
    8.2 Asia-Pacific Infectious Diseases In Vitro Diagnostics Consumption Value by Application (2019-2030)
    8.3 Asia-Pacific Infectious Diseases In Vitro Diagnostics Market Size by Region
        8.3.1 Asia-Pacific Infectious Diseases In Vitro Diagnostics Consumption Value by Region (2019-2030)
        8.3.2 China Infectious Diseases In Vitro Diagnostics Market Size and Forecast (2019-2030)
        8.3.3 Japan Infectious Diseases In Vitro Diagnostics Market Size and Forecast (2019-2030)
        8.3.4 South Korea Infectious Diseases In Vitro Diagnostics Market Size and Forecast (2019-2030)
        8.3.5 India Infectious Diseases In Vitro Diagnostics Market Size and Forecast (2019-2030)
        8.3.6 Southeast Asia Infectious Diseases In Vitro Diagnostics Market Size and Forecast (2019-2030)
        8.3.7 Australia Infectious Diseases In Vitro Diagnostics Market Size and Forecast (2019-2030)

9 South America
    9.1 South America Infectious Diseases In Vitro Diagnostics Consumption Value by Type (2019-2030)
    9.2 South America Infectious Diseases In Vitro Diagnostics Consumption Value by Application (2019-2030)
    9.3 South America Infectious Diseases In Vitro Diagnostics Market Size by Country
        9.3.1 South America Infectious Diseases In Vitro Diagnostics Consumption Value by Country (2019-2030)
        9.3.2 Brazil Infectious Diseases In Vitro Diagnostics Market Size and Forecast (2019-2030)
        9.3.3 Argentina Infectious Diseases In Vitro Diagnostics Market Size and Forecast (2019-2030)

10 Middle East & Africa
    10.1 Middle East & Africa Infectious Diseases In Vitro Diagnostics Consumption Value by Type (2019-2030)
    10.2 Middle East & Africa Infectious Diseases In Vitro Diagnostics Consumption Value by Application (2019-2030)
    10.3 Middle East & Africa Infectious Diseases In Vitro Diagnostics Market Size by Country
        10.3.1 Middle East & Africa Infectious Diseases In Vitro Diagnostics Consumption Value by Country (2019-2030)
        10.3.2 Turkey Infectious Diseases In Vitro Diagnostics Market Size and Forecast (2019-2030)
        10.3.3 Saudi Arabia Infectious Diseases In Vitro Diagnostics Market Size and Forecast (2019-2030)
        10.3.4 UAE Infectious Diseases In Vitro Diagnostics Market Size and Forecast (2019-2030)

11 Market Dynamics
    11.1 Infectious Diseases In Vitro Diagnostics Market Drivers
    11.2 Infectious Diseases In Vitro Diagnostics Market Restraints
    11.3 Infectious Diseases In Vitro Diagnostics Trends Analysis
    11.4 Porters Five Forces Analysis
        11.4.1 Threat of New Entrants
        11.4.2 Bargaining Power of Suppliers
        11.4.3 Bargaining Power of Buyers
        11.4.4 Threat of Substitutes
        11.4.5 Competitive Rivalry

12 Industry Chain Analysis
    12.1 Infectious Diseases In Vitro Diagnostics Industry Chain
    12.2 Infectious Diseases In Vitro Diagnostics Upstream Analysis
    12.3 Infectious Diseases In Vitro Diagnostics Midstream Analysis
    12.4 Infectious Diseases In Vitro Diagnostics Downstream Analysis

13 Research Findings and Conclusion

14 Appendix
    14.1 Methodology
    14.2 Research Process and Data Source
    14.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Infectious Diseases In Vitro Diagnostics Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
    Table 2. Global Infectious Diseases In Vitro Diagnostics Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
    Table 3. Global Infectious Diseases In Vitro Diagnostics Consumption Value by Region (2019-2024) & (USD Million)
    Table 4. Global Infectious Diseases In Vitro Diagnostics Consumption Value by Region (2025-2030) & (USD Million)
    Table 5. BD Company Information, Head Office, and Major Competitors
    Table 6. BD Major Business
    Table 7. BD Infectious Diseases In Vitro Diagnostics Product and Solutions
    Table 8. BD Infectious Diseases In Vitro Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 9. BD Recent Developments and Future Plans
    Table 10. Abbott Company Information, Head Office, and Major Competitors
    Table 11. Abbott Major Business
    Table 12. Abbott Infectious Diseases In Vitro Diagnostics Product and Solutions
    Table 13. Abbott Infectious Diseases In Vitro Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 14. Abbott Recent Developments and Future Plans
    Table 15. Alere Company Information, Head Office, and Major Competitors
    Table 16. Alere Major Business
    Table 17. Alere Infectious Diseases In Vitro Diagnostics Product and Solutions
    Table 18. Alere Infectious Diseases In Vitro Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 19. Alere Recent Developments and Future Plans
    Table 20. Quidel Company Information, Head Office, and Major Competitors
    Table 21. Quidel Major Business
    Table 22. Quidel Infectious Diseases In Vitro Diagnostics Product and Solutions
    Table 23. Quidel Infectious Diseases In Vitro Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 24. Quidel Recent Developments and Future Plans
    Table 25. F. Hoffmann-La Roche Company Information, Head Office, and Major Competitors
    Table 26. F. Hoffmann-La Roche Major Business
    Table 27. F. Hoffmann-La Roche Infectious Diseases In Vitro Diagnostics Product and Solutions
    Table 28. F. Hoffmann-La Roche Infectious Diseases In Vitro Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 29. F. Hoffmann-La Roche Recent Developments and Future Plans
    Table 30. Orasure Technologies Company Information, Head Office, and Major Competitors
    Table 31. Orasure Technologies Major Business
    Table 32. Orasure Technologies Infectious Diseases In Vitro Diagnostics Product and Solutions
    Table 33. Orasure Technologies Infectious Diseases In Vitro Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 34. Orasure Technologies Recent Developments and Future Plans
    Table 35. Cepheid Company Information, Head Office, and Major Competitors
    Table 36. Cepheid Major Business
    Table 37. Cepheid Infectious Diseases In Vitro Diagnostics Product and Solutions
    Table 38. Cepheid Infectious Diseases In Vitro Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 39. Cepheid Recent Developments and Future Plans
    Table 40. Hologic Company Information, Head Office, and Major Competitors
    Table 41. Hologic Major Business
    Table 42. Hologic Infectious Diseases In Vitro Diagnostics Product and Solutions
    Table 43. Hologic Infectious Diseases In Vitro Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 44. Hologic Recent Developments and Future Plans
    Table 45. Qiagen Company Information, Head Office, and Major Competitors
    Table 46. Qiagen Major Business
    Table 47. Qiagen Infectious Diseases In Vitro Diagnostics Product and Solutions
    Table 48. Qiagen Infectious Diseases In Vitro Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 49. Qiagen Recent Developments and Future Plans
    Table 50. Bio-Rad Laboratories Company Information, Head Office, and Major Competitors
    Table 51. Bio-Rad Laboratories Major Business
    Table 52. Bio-Rad Laboratories Infectious Diseases In Vitro Diagnostics Product and Solutions
    Table 53. Bio-Rad Laboratories Infectious Diseases In Vitro Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 54. Bio-Rad Laboratories Recent Developments and Future Plans
    Table 55. Siemens Healthcare Company Information, Head Office, and Major Competitors
    Table 56. Siemens Healthcare Major Business
    Table 57. Siemens Healthcare Infectious Diseases In Vitro Diagnostics Product and Solutions
    Table 58. Siemens Healthcare Infectious Diseases In Vitro Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 59. Siemens Healthcare Recent Developments and Future Plans
    Table 60. Global Infectious Diseases In Vitro Diagnostics Revenue (USD Million) by Players (2019-2024)
    Table 61. Global Infectious Diseases In Vitro Diagnostics Revenue Share by Players (2019-2024)
    Table 62. Breakdown of Infectious Diseases In Vitro Diagnostics by Company Type (Tier 1, Tier 2, and Tier 3)
    Table 63. Market Position of Players in Infectious Diseases In Vitro Diagnostics, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
    Table 64. Head Office of Key Infectious Diseases In Vitro Diagnostics Players
    Table 65. Infectious Diseases In Vitro Diagnostics Market: Company Product Type Footprint
    Table 66. Infectious Diseases In Vitro Diagnostics Market: Company Product Application Footprint
    Table 67. Infectious Diseases In Vitro Diagnostics New Market Entrants and Barriers to Market Entry
    Table 68. Infectious Diseases In Vitro Diagnostics Mergers, Acquisition, Agreements, and Collaborations
    Table 69. Global Infectious Diseases In Vitro Diagnostics Consumption Value (USD Million) by Type (2019-2024)
    Table 70. Global Infectious Diseases In Vitro Diagnostics Consumption Value Share by Type (2019-2024)
    Table 71. Global Infectious Diseases In Vitro Diagnostics Consumption Value Forecast by Type (2025-2030)
    Table 72. Global Infectious Diseases In Vitro Diagnostics Consumption Value by Application (2019-2024)
    Table 73. Global Infectious Diseases In Vitro Diagnostics Consumption Value Forecast by Application (2025-2030)
    Table 74. North America Infectious Diseases In Vitro Diagnostics Consumption Value by Type (2019-2024) & (USD Million)
    Table 75. North America Infectious Diseases In Vitro Diagnostics Consumption Value by Type (2025-2030) & (USD Million)
    Table 76. North America Infectious Diseases In Vitro Diagnostics Consumption Value by Application (2019-2024) & (USD Million)
    Table 77. North America Infectious Diseases In Vitro Diagnostics Consumption Value by Application (2025-2030) & (USD Million)
    Table 78. North America Infectious Diseases In Vitro Diagnostics Consumption Value by Country (2019-2024) & (USD Million)
    Table 79. North America Infectious Diseases In Vitro Diagnostics Consumption Value by Country (2025-2030) & (USD Million)
    Table 80. Europe Infectious Diseases In Vitro Diagnostics Consumption Value by Type (2019-2024) & (USD Million)
    Table 81. Europe Infectious Diseases In Vitro Diagnostics Consumption Value by Type (2025-2030) & (USD Million)
    Table 82. Europe Infectious Diseases In Vitro Diagnostics Consumption Value by Application (2019-2024) & (USD Million)
    Table 83. Europe Infectious Diseases In Vitro Diagnostics Consumption Value by Application (2025-2030) & (USD Million)
    Table 84. Europe Infectious Diseases In Vitro Diagnostics Consumption Value by Country (2019-2024) & (USD Million)
    Table 85. Europe Infectious Diseases In Vitro Diagnostics Consumption Value by Country (2025-2030) & (USD Million)
    Table 86. Asia-Pacific Infectious Diseases In Vitro Diagnostics Consumption Value by Type (2019-2024) & (USD Million)
    Table 87. Asia-Pacific Infectious Diseases In Vitro Diagnostics Consumption Value by Type (2025-2030) & (USD Million)
    Table 88. Asia-Pacific Infectious Diseases In Vitro Diagnostics Consumption Value by Application (2019-2024) & (USD Million)
    Table 89. Asia-Pacific Infectious Diseases In Vitro Diagnostics Consumption Value by Application (2025-2030) & (USD Million)
    Table 90. Asia-Pacific Infectious Diseases In Vitro Diagnostics Consumption Value by Region (2019-2024) & (USD Million)
    Table 91. Asia-Pacific Infectious Diseases In Vitro Diagnostics Consumption Value by Region (2025-2030) & (USD Million)
    Table 92. South America Infectious Diseases In Vitro Diagnostics Consumption Value by Type (2019-2024) & (USD Million)
    Table 93. South America Infectious Diseases In Vitro Diagnostics Consumption Value by Type (2025-2030) & (USD Million)
    Table 94. South America Infectious Diseases In Vitro Diagnostics Consumption Value by Application (2019-2024) & (USD Million)
    Table 95. South America Infectious Diseases In Vitro Diagnostics Consumption Value by Application (2025-2030) & (USD Million)
    Table 96. South America Infectious Diseases In Vitro Diagnostics Consumption Value by Country (2019-2024) & (USD Million)
    Table 97. South America Infectious Diseases In Vitro Diagnostics Consumption Value by Country (2025-2030) & (USD Million)
    Table 98. Middle East & Africa Infectious Diseases In Vitro Diagnostics Consumption Value by Type (2019-2024) & (USD Million)
    Table 99. Middle East & Africa Infectious Diseases In Vitro Diagnostics Consumption Value by Type (2025-2030) & (USD Million)
    Table 100. Middle East & Africa Infectious Diseases In Vitro Diagnostics Consumption Value by Application (2019-2024) & (USD Million)
    Table 101. Middle East & Africa Infectious Diseases In Vitro Diagnostics Consumption Value by Application (2025-2030) & (USD Million)
    Table 102. Middle East & Africa Infectious Diseases In Vitro Diagnostics Consumption Value by Country (2019-2024) & (USD Million)
    Table 103. Middle East & Africa Infectious Diseases In Vitro Diagnostics Consumption Value by Country (2025-2030) & (USD Million)
    Table 104. Infectious Diseases In Vitro Diagnostics Raw Material
    Table 105. Key Suppliers of Infectious Diseases In Vitro Diagnostics Raw Materials
List of Figures
    Figure 1. Infectious Diseases In Vitro Diagnostics Picture
    Figure 2. Global Infectious Diseases In Vitro Diagnostics Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
    Figure 3. Global Infectious Diseases In Vitro Diagnostics Consumption Value Market Share by Type in 2023
    Figure 4. MRSA
    Figure 5. Streptococcus
    Figure 6. TB and Drug-resistant TB
    Figure 7. Gastro-intestinal Panel Testing
    Figure 8. HIV
    Figure 9. Hepatitis C
    Figure 10. Others
    Figure 11. Global Infectious Diseases In Vitro Diagnostics Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
    Figure 12. Infectious Diseases In Vitro Diagnostics Consumption Value Market Share by Application in 2023
    Figure 13. Immunochemistry Picture
    Figure 14. Molecular Diagnostics Picture
    Figure 15. Microbiology Picture
    Figure 16. Others Picture
    Figure 17. Global Infectious Diseases In Vitro Diagnostics Consumption Value, (USD Million): 2019 & 2023 & 2030
    Figure 18. Global Infectious Diseases In Vitro Diagnostics Consumption Value and Forecast (2019-2030) & (USD Million)
    Figure 19. Global Market Infectious Diseases In Vitro Diagnostics Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
    Figure 20. Global Infectious Diseases In Vitro Diagnostics Consumption Value Market Share by Region (2019-2030)
    Figure 21. Global Infectious Diseases In Vitro Diagnostics Consumption Value Market Share by Region in 2023
    Figure 22. North America Infectious Diseases In Vitro Diagnostics Consumption Value (2019-2030) & (USD Million)
    Figure 23. Europe Infectious Diseases In Vitro Diagnostics Consumption Value (2019-2030) & (USD Million)
    Figure 24. Asia-Pacific Infectious Diseases In Vitro Diagnostics Consumption Value (2019-2030) & (USD Million)
    Figure 25. South America Infectious Diseases In Vitro Diagnostics Consumption Value (2019-2030) & (USD Million)
    Figure 26. Middle East and Africa Infectious Diseases In Vitro Diagnostics Consumption Value (2019-2030) & (USD Million)
    Figure 27. Global Infectious Diseases In Vitro Diagnostics Revenue Share by Players in 2023
    Figure 28. Infectious Diseases In Vitro Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
    Figure 29. Global Top 3 Players Infectious Diseases In Vitro Diagnostics Market Share in 2023
    Figure 30. Global Top 6 Players Infectious Diseases In Vitro Diagnostics Market Share in 2023
    Figure 31. Global Infectious Diseases In Vitro Diagnostics Consumption Value Share by Type (2019-2024)
    Figure 32. Global Infectious Diseases In Vitro Diagnostics Market Share Forecast by Type (2025-2030)
    Figure 33. Global Infectious Diseases In Vitro Diagnostics Consumption Value Share by Application (2019-2024)
    Figure 34. Global Infectious Diseases In Vitro Diagnostics Market Share Forecast by Application (2025-2030)
    Figure 35. North America Infectious Diseases In Vitro Diagnostics Consumption Value Market Share by Type (2019-2030)
    Figure 36. North America Infectious Diseases In Vitro Diagnostics Consumption Value Market Share by Application (2019-2030)
    Figure 37. North America Infectious Diseases In Vitro Diagnostics Consumption Value Market Share by Country (2019-2030)
    Figure 38. United States Infectious Diseases In Vitro Diagnostics Consumption Value (2019-2030) & (USD Million)
    Figure 39. Canada Infectious Diseases In Vitro Diagnostics Consumption Value (2019-2030) & (USD Million)
    Figure 40. Mexico Infectious Diseases In Vitro Diagnostics Consumption Value (2019-2030) & (USD Million)
    Figure 41. Europe Infectious Diseases In Vitro Diagnostics Consumption Value Market Share by Type (2019-2030)
    Figure 42. Europe Infectious Diseases In Vitro Diagnostics Consumption Value Market Share by Application (2019-2030)
    Figure 43. Europe Infectious Diseases In Vitro Diagnostics Consumption Value Market Share by Country (2019-2030)
    Figure 44. Germany Infectious Diseases In Vitro Diagnostics Consumption Value (2019-2030) & (USD Million)
    Figure 45. France Infectious Diseases In Vitro Diagnostics Consumption Value (2019-2030) & (USD Million)
    Figure 46. United Kingdom Infectious Diseases In Vitro Diagnostics Consumption Value (2019-2030) & (USD Million)
    Figure 47. Russia Infectious Diseases In Vitro Diagnostics Consumption Value (2019-2030) & (USD Million)
    Figure 48. Italy Infectious Diseases In Vitro Diagnostics Consumption Value (2019-2030) & (USD Million)
    Figure 49. Asia-Pacific Infectious Diseases In Vitro Diagnostics Consumption Value Market Share by Type (2019-2030)
    Figure 50. Asia-Pacific Infectious Diseases In Vitro Diagnostics Consumption Value Market Share by Application (2019-2030)
    Figure 51. Asia-Pacific Infectious Diseases In Vitro Diagnostics Consumption Value Market Share by Region (2019-2030)
    Figure 52. China Infectious Diseases In Vitro Diagnostics Consumption Value (2019-2030) & (USD Million)
    Figure 53. Japan Infectious Diseases In Vitro Diagnostics Consumption Value (2019-2030) & (USD Million)
    Figure 54. South Korea Infectious Diseases In Vitro Diagnostics Consumption Value (2019-2030) & (USD Million)
    Figure 55. India Infectious Diseases In Vitro Diagnostics Consumption Value (2019-2030) & (USD Million)
    Figure 56. Southeast Asia Infectious Diseases In Vitro Diagnostics Consumption Value (2019-2030) & (USD Million)
    Figure 57. Australia Infectious Diseases In Vitro Diagnostics Consumption Value (2019-2030) & (USD Million)
    Figure 58. South America Infectious Diseases In Vitro Diagnostics Consumption Value Market Share by Type (2019-2030)
    Figure 59. South America Infectious Diseases In Vitro Diagnostics Consumption Value Market Share by Application (2019-2030)
    Figure 60. South America Infectious Diseases In Vitro Diagnostics Consumption Value Market Share by Country (2019-2030)
    Figure 61. Brazil Infectious Diseases In Vitro Diagnostics Consumption Value (2019-2030) & (USD Million)
    Figure 62. Argentina Infectious Diseases In Vitro Diagnostics Consumption Value (2019-2030) & (USD Million)
    Figure 63. Middle East and Africa Infectious Diseases In Vitro Diagnostics Consumption Value Market Share by Type (2019-2030)
    Figure 64. Middle East and Africa Infectious Diseases In Vitro Diagnostics Consumption Value Market Share by Application (2019-2030)
    Figure 65. Middle East and Africa Infectious Diseases In Vitro Diagnostics Consumption Value Market Share by Country (2019-2030)
    Figure 66. Turkey Infectious Diseases In Vitro Diagnostics Consumption Value (2019-2030) & (USD Million)
    Figure 67. Saudi Arabia Infectious Diseases In Vitro Diagnostics Consumption Value (2019-2030) & (USD Million)
    Figure 68. UAE Infectious Diseases In Vitro Diagnostics Consumption Value (2019-2030) & (USD Million)
    Figure 69. Infectious Diseases In Vitro Diagnostics Market Drivers
    Figure 70. Infectious Diseases In Vitro Diagnostics Market Restraints
    Figure 71. Infectious Diseases In Vitro Diagnostics Market Trends
    Figure 72. Porters Five Forces Analysis
    Figure 73. Manufacturing Cost Structure Analysis of Infectious Diseases In Vitro Diagnostics in 2023
    Figure 74. Manufacturing Process Analysis of Infectious Diseases In Vitro Diagnostics
    Figure 75. Infectious Diseases In Vitro Diagnostics Industrial Chain
    Figure 76. Methodology
    Figure 77. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

BD
Abbott
Alere
Quidel
F. Hoffmann-La Roche
Orasure Technologies
Cepheid
Hologic
Qiagen
Bio-Rad Laboratories
Siemens Healthcare

Related Reports

Global Infectious Diseases In Vitro Diagnostics Supply, Demand and Key Producers, 2023-2029

Global Infectious Diseases In Vitro Diagnostics Supply, Demand and Key Producers, 2023-2029

date 23 Feb 2023

date Medical Care

The global Infectious Diseases In Vitro Diagnostics market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

Product Tags

Infectious Diseases In Vitro Diagnostics

Organ Rejection Prophylaxis Treatment

Biologics Analytical Services

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>